Smith+Nephew Acquires CartiHeal for $180 Million

Smith+Nephew Acquires CartiHeal for $180 Million

After being acquired by Bioventus in April 2022 for $315 million upfront, CartiHeal is now changing hands. Smith+Nephew announced that it has entered into a definitive agreement to acquire CartiHeal, a privately held medical device company with headquarters in Israel.  Under the terms of the agreement, Smith+Nephew will pay an initial cash consideration of $180 million at closing, and up to a further $150 million contingent on financial performance.  CartiHeal develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. The company has developed Agili-C, a novel sports medicine technology for cartilage regeneration... Read More »
Smith+Nephew Acquires CartiHeal for $180 Million

Halma Strengthens Healthcare Sector with Acquisition of TeDan Companies

Halma, a global group of life-saving technology companies, is bolstering its Healthcare sector with a large acquisition.  Halma announced on November 20 that it is acquiring the TeDan group of companies, comprising the separate companies of TeDan Surgical Innovations, Inc., West Coast Surgical, LLC, Axcess Surgical Innovations, LLC and TeDan Surgical Innovations GmbH.  Headquartered in Sugar Land, Texas, just southwest of Houston, TeDan is a global leader in innovative surgical access systems. It develops, manufactures and supplies to surgeons for use in a range of acute therapeutic procedures. Its primary market is access systems for spinal surgery, and the United States... Read More »
Irish Company Arrotek Medical to Merge with U.S.-Based NeedleTech

Irish Company Arrotek Medical to Merge with U.S.-Based NeedleTech

Arrotek Medical, based in Sligo, Ireland, and North Attleboro, Massachusetts-based NeedleTech Products are merging under the Arrotek brand. Both Arrotek and NeedleTech have strong records in the medical device industry, serving a broad range of customers that include original equipment manufacturers, medical device startups and corporations.  NeedleTech Products is a leading contract development and manufacturing organization (CDMO) serving several markets, including interventional radiology, interventional oncology, sports medicine, pain management, pharmaceutical and spine. NeedleTech provides components and finished devices to many of the top medical device companies... Read More »
Medela Spins Off Wound Care Business to Combine with Medaxis

Medela Spins Off Wound Care Business to Combine with Medaxis

Medela is spinning off its wound care business, which will combine with Medaxis to form a new standalone wound care company.  Medela’s wound care business provides wound care solutions powered by Medela’s medical vacuum technology, including its negative pressure wound therapy line of products and services. As the healthcare of choice for more than 6 million hospitals and homes across the globe, Medela provides a research-based breast milk feeding and baby products, healthcare solutions for hospitals and clinical education. The company has 20 subsidiaries in Europe, the Americas, Asia and Australia, three production and warehouse facilities in Switzerland, the United States and China... Read More »
AMETEK Acquires Paragon Medical for $1.9 Billion

AMETEK Acquires Paragon Medical for $1.9 Billion

AMETEK, Inc. announced that it has entered into a definitive agreement to acquire Paragon Medical from affiliates of American Securities LLC. The all-cash transaction is valued at approximately $1.9 billion.  Paragon Medical, formerly MW Life Sciences, offers advanced medical manufacturing and design for medical devices, components and products. It is based in Pierceton, Indiana. Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery and drug delivery. Paragon’s product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of... Read More »
Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Corp. (NYSE: DHR), a well-known player in the medical device market, recently unveiled its third-quarter financial results on October 24. With a global presence, Danaher specializes in the design, manufacture and distribution of professional, medical, industrial and commercial products and services. The latest earnings report painted a somber picture for Danaher, as the company grappled with a decline in both sales and profits compared to the previous year. This underwhelming performance came as the pharma and biotech sectors experienced a broader loss of momentum in critical markets. “Pharma and biotech took a modest step down, and that was particularly the case in the U.S. In... Read More »